Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


Revenue 2017


The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Sanofi's 2013 sales performance.


CLEAR HORIZONS: A New Era of Psoriasis Care

Sponsored by. by Lucid Group for Sanofi Genzyme. ... by Lucid Group for Sanofi Genzyme.

Azafaros expands executive team with three senior hires

Azafaros expands executive team with three senior hires Rounding out the new hires is Louise Kooij, who joins as head of finance and operations from Sanofi-Genzyme. ... While at Sanofi, she served as head of rare diseases, Central and Eastern Europe – in this role, she led all commercial activities for rare

The 90TEN Award for Excellence in Corporate Communications – Internal Stakeholders

by Sanofi. In 2019, Sanofi opened a new UK headquarters, consolidating three offices into one location. ... The communications around the move led the awareness and acceptance of activity-based working, which has led to greater connectivity,

Excellence in Global Education Meetings/Stand-Alone Events

by Lucid Group for Sanofi Genzyme. RA is a chronic disease affecting up to 1% of the worldwide population. ... Sanofi Genzyme Regeneron, assisted by Team Unity – a Lucid Group Company, launched LiBRA, an international education programme that aims to

AI and genomics: a revolution in drug discovery and development

AI and genomics: a revolution in drug discovery and development Likewise, Sanofi has partnered with Exscientia to use its artificial intelligence technology to find potentials targets for metabolic disease therapies.

[ Previous 5 results ] 8 9 10 11 12 13 14 15 16 17 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs


Add my company
McCann Health Medical Communications

We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....

Latest intelligence

Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...
Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset...